Professor K Ray Chaudhuri MD, DSc, FRCP, FEAN
Professor of Movement Disorders and Neurology
Research interests
- Neuroscience
Biography
My research concerns Parkinson's Disease and in particular, pioneering work on defining non-motor symptoms and non-motor phenotypes of Parkinson's disease. I am considered a world leader in non-motor aspects of Parkinson's people-based research. To date, I have published over 350 peer-reviewed papers, several book chapters on Parkinson's Disease, restless legs syndrome and dystonia. I am also the director of Parkinson's Foundation Centre of Excellence at King's, Research Director and Assistant Medical Director at King's College Hospital.
Please see my Research Staff Profile for more detail.
Find out more about my research:
Key publications:
- Chaudhuri et al., 2019. The movement disorder society nonmotor rating scale: Initial validation study. Mov Disord.
- Chaudhuri et al., 2015. King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation. Mov Disord.
- Chaudhuri et al., 2009. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol.
- Chaudhuri et al., 2006. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord.
- Chaudhuri et al., 2006. Non-motor symptoms of Parkinson's disease: diagnosis and management. The Lancet.
Key collaborators:
- Dr Pablo Martinez-Martin, Carlos III Institute of Health
- Professor Per Odin, Lund University
- Professor Angelo Antonini, University of Padua
- Professor Dag Aarsland, King's College London
Research
SHAPER - Scaling-up Health Arts Programmes: Implementation and Effectiveness Research
SHAPER is a programme that will assess the effectiveness and implementation of 3 arts-in-health, Melodies for Mums with Postnatal Depression, Dance for Parkinson’s, Stroke Odysseys.
The RHAPSODY Study
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)
Project status: Ongoing
Cannabidiol for Parkinson’s Disease Psychosis (CAN-PDP) Trial
Multi-centre trial of cannabidiol (CBD) for the treatment of Parkinson's disease psychosis
Project status: Ongoing
News
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis
Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson’s disease and a potential therapeutic target
IoPPN host delegation from Republic of Indonesia Ministry of Health
Visit underlines partnership and collaboration in the use of electronic health records and digital therapies, and for a new Perinatal Mental Health Centre in...
King's College Hospital Chief Officers Visit Maurice Wohl Clinical Neuroscience Institute
Professor Clive Kay and Dr Leonie Penna met with School of Neuroscience researchers to learn about clinical and academic partnerships.
King's researchers develop new approach to attract diverse recruitment in research studies
Researchers at King’s College London have developed a new approach to research study recruitment, called the ‘King’s Model’ to attract people from diverse...
Professor K Ray Chaudhuri receives award from International Parkinson & Movement Disorders Society
The Honorary Membership Award, which recognizes persons who have made extraordinary contributions to the field of Movement Disorders, was presented to...
Developing and researching arts in health interventions at King's
This seminar introduced the SHAPER programme at King's College London and invited collaboration from researchers
Features
The Use of Wearable in Parkinson's Disease Research
Parkinson’s Disease (PD) is the most common neurodegenerative disease, but it is currently incurable. Our recent publication looks at the use of wearable...
IoPPN Research Festival 2024 'Origins and new beginnings'
The 2024 IoPPN Research Festival covered the theme ‘Origins and New Beginnings.’
Research
SHAPER - Scaling-up Health Arts Programmes: Implementation and Effectiveness Research
SHAPER is a programme that will assess the effectiveness and implementation of 3 arts-in-health, Melodies for Mums with Postnatal Depression, Dance for Parkinson’s, Stroke Odysseys.
The RHAPSODY Study
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric disorders (RHAPSODY)
Project status: Ongoing
Cannabidiol for Parkinson’s Disease Psychosis (CAN-PDP) Trial
Multi-centre trial of cannabidiol (CBD) for the treatment of Parkinson's disease psychosis
Project status: Ongoing
News
Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis
Reduced brain activity responding to unpredicted visual changes is a marker of psychosis in Parkinson’s disease and a potential therapeutic target
IoPPN host delegation from Republic of Indonesia Ministry of Health
Visit underlines partnership and collaboration in the use of electronic health records and digital therapies, and for a new Perinatal Mental Health Centre in...
King's College Hospital Chief Officers Visit Maurice Wohl Clinical Neuroscience Institute
Professor Clive Kay and Dr Leonie Penna met with School of Neuroscience researchers to learn about clinical and academic partnerships.
King's researchers develop new approach to attract diverse recruitment in research studies
Researchers at King’s College London have developed a new approach to research study recruitment, called the ‘King’s Model’ to attract people from diverse...
Professor K Ray Chaudhuri receives award from International Parkinson & Movement Disorders Society
The Honorary Membership Award, which recognizes persons who have made extraordinary contributions to the field of Movement Disorders, was presented to...
Developing and researching arts in health interventions at King's
This seminar introduced the SHAPER programme at King's College London and invited collaboration from researchers
Features
The Use of Wearable in Parkinson's Disease Research
Parkinson’s Disease (PD) is the most common neurodegenerative disease, but it is currently incurable. Our recent publication looks at the use of wearable...
IoPPN Research Festival 2024 'Origins and new beginnings'
The 2024 IoPPN Research Festival covered the theme ‘Origins and New Beginnings.’